[email protected]
CDI - Contrive Datum Insights
Medical Devices

Radiation Oncology MarketSize, Share & Industry Analysis, 2026-2034By Treatment ModalityBy TechniqueBy Product and Service OfferingBy Cancer TypeBy Treatment IntentBy Fractionation RegimenBy End UserBy Patient Age GroupBy Procurement Model

Full title & scope — all 9 axes with their segments

Radiation Oncology Market Size, Share & Industry Analysis, By Treatment Modality (External Beam Radiation Therapy, Proton Therapy, Carbon Ion Therapy, Brachytherapy, Systemic Radioisotope Therapy, Intraoperative Radiotherapy), By Technique (3D Conformal Radiotherapy, Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Image-Guided Radiotherapy, Stereotactic Radiotherapy, Adaptive Radiotherapy), By Product and Service Offering (Treatment Delivery Systems, Treatment Planning Software, Oncology Information Systems, Patient Positioning and Immobilization, Quality Assurance and Dosimetry, Radioisotopes and Sealed Sources, Installation, Maintenance and Upgrade Services), By Cancer Type (Prostate Cancer, Breast Cancer, Lung Cancer, Head and Neck Cancer, Colorectal Cancer, Brain and Central Nervous System Tumors, Gynecological Cancer, Other Cancers), By Treatment Intent (Curative, Adjuvant, Neoadjuvant, Palliative), By Fractionation Regimen (Conventional Fractionation, Moderate Hypofractionation, Ultra-Hypofractionation, Hyperfractionation, Accelerated Fractionation), By End User (Hospitals, Independent Radiotherapy Centers, Cancer Research Institutes, Ambulatory Oncology Clinics), By Patient Age Group (Pediatric, Adult, Geriatric), By Procurement Model (Outright Purchase, Leasing and Equipment-as-a-Service, Per-Procedure or Managed Service Contracts, Public Tender and Government Procurement), and Regional Forecast, 2026-2034

Last Updated: Nov 18, 2026Format: PDFReport ID: CDI-248917
TOC

Full table of contents for the published report, chapter by chapter.

Full chapter-and-section structure of the report. Segment, region, and company breakdowns are listed as scope. The underlying figures are in the sample and full report.

Table of Contents+
Chapter 1.Executive Summary
1.1Strategic Imperatives
1.2Definition
1.3Radiation Oncology Comparison By Segments
Chapter 2.Premium Insights
2.1Top 3 Trends to Watch
2.2Top 3 Strategies Followed by Major Players
2.3Top 3 Predictions by Contrive Datum Insights
2.4Top Investment Pockets
2.4.1Market Attractiveness Analysis, By Treatment Modality
2.4.2Market Attractiveness Analysis, By Technique
2.4.3Market Attractiveness Analysis, By Product and Service Offering
2.4.4Market Attractiveness Analysis, By Cancer Type
2.4.5Market Attractiveness Analysis, By Treatment Intent
2.4.6Market Attractiveness Analysis, By Fractionation Regimen
2.4.7Market Attractiveness Analysis, By End User
2.4.8Market Attractiveness Analysis, By Patient Age Group
2.4.9Market Attractiveness Analysis, By Procurement Model
2.5Key Market Participants — Intensity Mapping
2.6Insights From Primary Respondents
Chapter 3.Market Definition
Chapter 4.Research Methodology
4.1Research Approach
4.1.1Research Programs / Design
4.1.2Market Size Estimation
4.2Data Sources
4.2.1Secondary Sources
4.2.1.1Preliminary Data Mining
4.2.2Primary Sources
4.2.2.1Statistical Model
4.2.2.2Data Triangulation
4.2.2.3Research Objective
4.3Flow Of Methodology
4.4Top-Down / Bottom-Up Approach
Chapter 5.Strategic Imperatives & Market Outlook
Chapter 6.Go-to-Market (GTM) Strategies
6.1Market Focus & Value Proposition
6.1.1Target Customers, Priority Markets, and Core Value Proposition
6.1.2Product Differentiation and Positioning Logic
6.2Commercial Model & Pricing Strategy
6.2.1Pricing Approach and Value Capture
6.2.2Contracting, Bundling, and Monetization Framework
6.3Channels, Sales & Partnerships
6.3.1Direct and Indirect Channel Strategy
6.3.2Sales Execution Model and Strategic Partnerships
6.4Marketing, Launch & Execution Roadmap
6.4.1Marketing and Demand Generation Approach
6.4.2Launch Sequencing and Rollout Plan
6.5Operational Readiness & Governance KPIs
6.5.1Supply Chain and Operational Preparedness
6.5.2Regulatory Considerations, Risks, and Performance Tracking
Chapter 7.Market Trends, Strategy & Dynamics
7.1Trends Overview
7.2Strategic Overview
7.3Market Drivers
7.4Market Restraints
7.5Market Opportunities
7.6Market Challenges
7.7Impact Analysis of Market Dynamics
Chapter 8.Porter's Five Forces
8.1Bargaining Power of Suppliers
8.2Bargaining Power of Buyers
8.3Threat of New Entrants
8.4Threat of Substitutes
8.5Competitive Rivalry
Chapter 9.PESTEL Analysis
9.1Political
9.2Economic
9.3Social
9.4Technological
9.5Environmental
9.6Legal
Chapter 10.Value Chain Analysis
Chapter 11.Supply Chain Analysis
Chapter 12.Macro-Economic Factors
12.1Macro-Economic Factors Overview
12.2Forecast Factors — Relevance and Impact
Chapter 13.Market Cost Analysis
13.1Key Raw Materials Analysis
13.1.1Key Raw Materials
13.1.2Price Trend of Key Raw Materials
13.1.3Key Suppliers of Raw Materials
13.1.4Market Concentration Rate of Raw Materials
13.1.5Raw Materials
13.1.6Labor Cost
Chapter 14.Market Supply-Side Analysis
14.1Raw Materials
14.2Price Trends
14.3Industry Chain
14.4Raw Materials Sourcing
14.5Raw Materials Sources of Major Manufacturers
14.6Downstream Buyers
Chapter 15.Global Radiation Oncology Market Size & Projections, 2020–2034, Revenue (USD Billion)
15.1Global Radiation Oncology Market Size — Total
15.2Market Size, by Segment (By Treatment Modality, By Technique, By Product and Service Offering, By Cancer Type, By Treatment Intent, By Fractionation Regimen, By End User, By Patient Age Group, By Procurement Model)
Chapter 16.Global Radiation Oncology Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
16.1Introduction
16.2Global Radiation Oncology Market Size, By Treatment Modality, 2020–2034, Revenue (USD Billion)
16.3Global Radiation Oncology Market Share, By Treatment Modality (%)
16.3.1External Beam Radiation Therapy
16.3.1.1Market Size, By External Beam Radiation Therapy, 2020–2034, Revenue (USD Billion)
16.3.1.2External Beam Radiation Therapy Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
16.3.1.3External Beam Radiation Therapy Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
16.3.1.4External Beam Radiation Therapy Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
16.3.1.5External Beam Radiation Therapy Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
16.3.1.6External Beam Radiation Therapy Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
16.3.1.7External Beam Radiation Therapy Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
16.3.1.8External Beam Radiation Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
16.3.1.9External Beam Radiation Therapy Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
16.3.2Proton Therapy
16.3.3Carbon Ion Therapy
16.3.4Brachytherapy
16.3.5Systemic Radioisotope Therapy
16.3.6Intraoperative Radiotherapy
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 16.3.1 (External Beam Radiation Therapy).
Chapter 17.Global Radiation Oncology Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
17.1Introduction
17.2Global Radiation Oncology Market Size, By Technique, 2020–2034, Revenue (USD Billion)
17.3Global Radiation Oncology Market Share, By Technique (%)
17.3.13D Conformal Radiotherapy
17.3.1.1Market Size, By 3D Conformal Radiotherapy, 2020–2034, Revenue (USD Billion)
17.3.1.23D Conformal Radiotherapy Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
17.3.1.33D Conformal Radiotherapy Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
17.3.1.43D Conformal Radiotherapy Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
17.3.1.53D Conformal Radiotherapy Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
17.3.1.63D Conformal Radiotherapy Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
17.3.1.73D Conformal Radiotherapy Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
17.3.1.83D Conformal Radiotherapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
17.3.1.93D Conformal Radiotherapy Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
17.3.2Intensity-Modulated Radiotherapy
17.3.3Volumetric Modulated Arc Therapy
17.3.4Image-Guided Radiotherapy
17.3.5Stereotactic Radiotherapy
17.3.6Adaptive Radiotherapy
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 17.3.1 (3D Conformal Radiotherapy).
Chapter 18.Global Radiation Oncology Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
18.1Introduction
18.2Global Radiation Oncology Market Size, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
18.3Global Radiation Oncology Market Share, By Product and Service Offering (%)
18.3.1Treatment Delivery Systems
18.3.1.1Market Size, By Treatment Delivery Systems, 2020–2034, Revenue (USD Billion)
18.3.1.2Treatment Delivery Systems Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
18.3.1.3Treatment Delivery Systems Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
18.3.1.4Treatment Delivery Systems Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
18.3.1.5Treatment Delivery Systems Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
18.3.1.6Treatment Delivery Systems Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
18.3.1.7Treatment Delivery Systems Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
18.3.1.8Treatment Delivery Systems Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
18.3.1.9Treatment Delivery Systems Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
18.3.2Treatment Planning Software
18.3.3Oncology Information Systems
18.3.4Patient Positioning and Immobilization
18.3.5Quality Assurance and Dosimetry
18.3.6Radioisotopes and Sealed Sources
18.3.7Installation, Maintenance and Upgrade Services
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 18.3.1 (Treatment Delivery Systems).
Chapter 19.Global Radiation Oncology Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
19.1Introduction
19.2Global Radiation Oncology Market Size, By Cancer Type, 2020–2034, Revenue (USD Billion)
19.3Global Radiation Oncology Market Share, By Cancer Type (%)
19.3.1Prostate Cancer
19.3.1.1Market Size, By Prostate Cancer, 2020–2034, Revenue (USD Billion)
19.3.1.2Prostate Cancer Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
19.3.1.3Prostate Cancer Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
19.3.1.4Prostate Cancer Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
19.3.1.5Prostate Cancer Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
19.3.1.6Prostate Cancer Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
19.3.1.7Prostate Cancer Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
19.3.1.8Prostate Cancer Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
19.3.1.9Prostate Cancer Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
19.3.2Breast Cancer
19.3.3Lung Cancer
19.3.4Head and Neck Cancer
19.3.5Colorectal Cancer
19.3.6Brain and Central Nervous System Tumors
19.3.7Gynecological Cancer
19.3.8Other Cancers
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 19.3.1 (Prostate Cancer).
Chapter 20.Global Radiation Oncology Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
20.1Introduction
20.2Global Radiation Oncology Market Size, By Treatment Intent, 2020–2034, Revenue (USD Billion)
20.3Global Radiation Oncology Market Share, By Treatment Intent (%)
20.3.1Curative
20.3.1.1Market Size, By Curative, 2020–2034, Revenue (USD Billion)
20.3.1.2Curative Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
20.3.1.3Curative Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
20.3.1.4Curative Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
20.3.1.5Curative Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
20.3.1.6Curative Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
20.3.1.7Curative Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
20.3.1.8Curative Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
20.3.1.9Curative Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
20.3.2Adjuvant
20.3.3Neoadjuvant
20.3.4Palliative
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 20.3.1 (Curative).
Chapter 21.Global Radiation Oncology Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
21.1Introduction
21.2Global Radiation Oncology Market Size, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
21.3Global Radiation Oncology Market Share, By Fractionation Regimen (%)
21.3.1Conventional Fractionation
21.3.1.1Market Size, By Conventional Fractionation, 2020–2034, Revenue (USD Billion)
21.3.1.2Conventional Fractionation Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
21.3.1.3Conventional Fractionation Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
21.3.1.4Conventional Fractionation Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
21.3.1.5Conventional Fractionation Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
21.3.1.6Conventional Fractionation Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
21.3.1.7Conventional Fractionation Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
21.3.1.8Conventional Fractionation Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
21.3.1.9Conventional Fractionation Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
21.3.2Moderate Hypofractionation
21.3.3Ultra-Hypofractionation
21.3.4Hyperfractionation
21.3.5Accelerated Fractionation
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 21.3.1 (Conventional Fractionation).
Chapter 22.Global Radiation Oncology Market Overview, By End User, 2020–2034, Revenue (USD Billion)
22.1Introduction
22.2Global Radiation Oncology Market Size, By End User, 2020–2034, Revenue (USD Billion)
22.3Global Radiation Oncology Market Share, By End User (%)
22.3.1Hospitals
22.3.1.1Market Size, By Hospitals, 2020–2034, Revenue (USD Billion)
22.3.1.2Hospitals Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
22.3.1.3Hospitals Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
22.3.1.4Hospitals Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
22.3.1.5Hospitals Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
22.3.1.6Hospitals Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
22.3.1.7Hospitals Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
22.3.1.8Hospitals Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
22.3.1.9Hospitals Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
22.3.2Independent Radiotherapy Centers
22.3.3Cancer Research Institutes
22.3.4Ambulatory Oncology Clinics
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 22.3.1 (Hospitals).
Chapter 23.Global Radiation Oncology Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
23.1Introduction
23.2Global Radiation Oncology Market Size, By Patient Age Group, 2020–2034, Revenue (USD Billion)
23.3Global Radiation Oncology Market Share, By Patient Age Group (%)
23.3.1Pediatric
23.3.1.1Market Size, By Pediatric, 2020–2034, Revenue (USD Billion)
23.3.1.2Pediatric Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
23.3.1.3Pediatric Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
23.3.1.4Pediatric Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
23.3.1.5Pediatric Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
23.3.1.6Pediatric Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
23.3.1.7Pediatric Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
23.3.1.8Pediatric Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
23.3.1.9Pediatric Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
23.3.2Adult
23.3.3Geriatric
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 23.3.1 (Pediatric).
Chapter 24.Global Radiation Oncology Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
24.1Introduction
24.2Global Radiation Oncology Market Size, By Procurement Model, 2020–2034, Revenue (USD Billion)
24.3Global Radiation Oncology Market Share, By Procurement Model (%)
24.3.1Outright Purchase
24.3.1.1Market Size, By Outright Purchase, 2020–2034, Revenue (USD Billion)
24.3.1.2Outright Purchase Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
24.3.1.3Outright Purchase Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
24.3.1.4Outright Purchase Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
24.3.1.5Outright Purchase Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
24.3.1.6Outright Purchase Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
24.3.1.7Outright Purchase Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
24.3.1.8Outright Purchase Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
24.3.1.9Outright Purchase Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
24.3.2Leasing and Equipment-as-a-Service
24.3.3Per-Procedure or Managed Service Contracts
24.3.4Public Tender and Government Procurement
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 24.3.1 (Outright Purchase).
Chapter 25.Global Radiation Oncology Market Size — Segment Comparison
Chapter 26.Global Radiation Oncology Geography Overview, 2020–2034, Revenue (USD Billion)
26.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
26.2Share, By Geography, 2020–2034 (%)
26.3Share, By Geography Analysis, 2025, Market Share and CAGR
26.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Chapter 27.North America Radiation Oncology Market Deep-Dive, 2020–2034, Revenue (USD Billion)
27.1Overview, 2020–2034
27.2Size and Projections, 2020–2034, Revenue (USD Billion)
27.2.1By Treatment Modality, 2020–2034
27.2.2By Technique, 2020–2034
27.2.3By Product and Service Offering, 2020–2034
27.2.4By Cancer Type, 2020–2034
27.2.5By Treatment Intent, 2020–2034
27.2.6By Fractionation Regimen, 2020–2034
27.2.7By End User, 2020–2034
27.2.8By Patient Age Group, 2020–2034
27.2.9By Procurement Model, 2020–2034
27.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
27.3.1US
27.3.1.1US — Key Country Dynamics
27.3.1.2US — Regulatory Framework
27.3.1.3US — Competitive Scenario
27.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
27.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
27.3.1.6US Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
27.3.1.7US Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
27.3.1.8US Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
27.3.1.9US Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
27.3.1.10US Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
27.3.1.11US Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
27.3.1.12US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
27.3.1.13US Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
27.3.1.14US Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
27.3.2Canada
27.3.3Mexico
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 27.3.1 (US).
Chapter 28.Europe Radiation Oncology Market Deep-Dive, 2020–2034, Revenue (USD Billion)
28.1Overview, 2020–2034
28.2Size and Projections, 2020–2034, Revenue (USD Billion)
28.2.1By Treatment Modality, 2020–2034
28.2.2By Technique, 2020–2034
28.2.3By Product and Service Offering, 2020–2034
28.2.4By Cancer Type, 2020–2034
28.2.5By Treatment Intent, 2020–2034
28.2.6By Fractionation Regimen, 2020–2034
28.2.7By End User, 2020–2034
28.2.8By Patient Age Group, 2020–2034
28.2.9By Procurement Model, 2020–2034
28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
28.3.1Germany
28.3.1.1Germany — Key Country Dynamics
28.3.1.2Germany — Regulatory Framework
28.3.1.3Germany — Competitive Scenario
28.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
28.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
28.3.1.6Germany Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
28.3.1.7Germany Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
28.3.1.8Germany Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
28.3.1.9Germany Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
28.3.1.10Germany Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
28.3.1.11Germany Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
28.3.1.12Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
28.3.1.13Germany Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
28.3.1.14Germany Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
28.3.2France
28.3.3Italy
28.3.4Spain
28.3.5UK
28.3.6Nordic Countries
28.3.7Benelux Union
28.3.8Rest of Europe
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 28.3.1 (Germany).
Chapter 29.Asia Pacific Radiation Oncology Market Deep-Dive, 2020–2034, Revenue (USD Billion)
29.1Overview, 2020–2034
29.2Size and Projections, 2020–2034, Revenue (USD Billion)
29.2.1By Treatment Modality, 2020–2034
29.2.2By Technique, 2020–2034
29.2.3By Product and Service Offering, 2020–2034
29.2.4By Cancer Type, 2020–2034
29.2.5By Treatment Intent, 2020–2034
29.2.6By Fractionation Regimen, 2020–2034
29.2.7By End User, 2020–2034
29.2.8By Patient Age Group, 2020–2034
29.2.9By Procurement Model, 2020–2034
29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
29.3.1India
29.3.1.1India — Key Country Dynamics
29.3.1.2India — Regulatory Framework
29.3.1.3India — Competitive Scenario
29.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
29.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
29.3.1.6India Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
29.3.1.7India Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
29.3.1.8India Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
29.3.1.9India Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
29.3.1.10India Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
29.3.1.11India Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
29.3.1.12India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
29.3.1.13India Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
29.3.1.14India Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
29.3.2Australia
29.3.3China
29.3.4China (Taiwan)
29.3.5Japan
29.3.6South Korea
29.3.7Southeast Asia
29.3.8Indonesia
29.3.9Thailand
29.3.10Malaysia
29.3.11Singapore
29.3.12Rest of Asia Pacific
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 29.3.1 (India).
Chapter 30.Latin America Radiation Oncology Market Deep-Dive, 2020–2034, Revenue (USD Billion)
30.1Overview, 2020–2034
30.2Size and Projections, 2020–2034, Revenue (USD Billion)
30.2.1By Treatment Modality, 2020–2034
30.2.2By Technique, 2020–2034
30.2.3By Product and Service Offering, 2020–2034
30.2.4By Cancer Type, 2020–2034
30.2.5By Treatment Intent, 2020–2034
30.2.6By Fractionation Regimen, 2020–2034
30.2.7By End User, 2020–2034
30.2.8By Patient Age Group, 2020–2034
30.2.9By Procurement Model, 2020–2034
30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
30.3.1Brazil
30.3.1.1Brazil — Key Country Dynamics
30.3.1.2Brazil — Regulatory Framework
30.3.1.3Brazil — Competitive Scenario
30.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
30.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
30.3.1.6Brazil Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
30.3.1.7Brazil Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
30.3.1.8Brazil Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
30.3.1.9Brazil Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
30.3.1.10Brazil Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
30.3.1.11Brazil Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
30.3.1.12Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
30.3.1.13Brazil Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
30.3.1.14Brazil Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
30.3.2Argentina
30.3.3Rest of Latin America
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 30.3.1 (Brazil).
Chapter 31.Middle East and Africa Radiation Oncology Market Deep-Dive, 2020–2034, Revenue (USD Billion)
31.1Overview, 2020–2034
31.2Size and Projections, 2020–2034, Revenue (USD Billion)
31.2.1By Treatment Modality, 2020–2034
31.2.2By Technique, 2020–2034
31.2.3By Product and Service Offering, 2020–2034
31.2.4By Cancer Type, 2020–2034
31.2.5By Treatment Intent, 2020–2034
31.2.6By Fractionation Regimen, 2020–2034
31.2.7By End User, 2020–2034
31.2.8By Patient Age Group, 2020–2034
31.2.9By Procurement Model, 2020–2034
31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
31.3.1GCC
31.3.1.1GCC — Key Country Dynamics
31.3.1.2GCC — Regulatory Framework
31.3.1.3GCC — Competitive Scenario
31.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
31.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
31.3.1.6GCC Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
31.3.1.7GCC Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
31.3.1.8GCC Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
31.3.1.9GCC Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
31.3.1.10GCC Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
31.3.1.11GCC Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
31.3.1.12GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
31.3.1.13GCC Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
31.3.1.14GCC Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
31.3.2Egypt
31.3.3South Africa
31.3.4Rest of the Middle East & Africa
Note: the data representation for every other item above adheres to the same structure and format demonstrated in section 31.3.1 (GCC).
Chapter 32.Application / Use-Case Analysis
Chapter 33.Vendor Capability Scorecard
Chapter 34.Scenario Forecasts
34.1Bull-case Trajectory
34.2Base-case Trajectory
34.3Bear-case Trajectory
Chapter 35.Top 10 Key Clients of Top 10 Players
Chapter 36.Top 10 Suppliers
Chapter 37.Competitive Landscape
37.1Siemens Healthineers AG (Varian Medical Systems, Inc.)
37.2Elekta AB
37.3Accuray Incorporated
37.4Ion Beam Applications S.A. (IBA)
37.5Hitachi, Ltd.
37.6Sumitomo Heavy Industries, Ltd.
37.7Mevion Medical Systems, Inc.
37.8Brainlab AG
37.9RaySearch Laboratories AB
37.10Mirion Technologies, Inc. (Sun Nuclear)
37.11Eckert & Ziegler SE
37.12Novartis AG
37.13Bayer AG
37.14Perspective Therapeutics, Inc.
37.15Theragenics Corporation
37.16CIVCO Medical Solutions
37.17Best Medical International, Inc.
37.18PTW-Freiburg GmbH
37.19Standard Imaging, Inc.
37.20Reflexion Medical, Inc.
37.21Our United Corporation
37.22Shinva Medical Instrument Co., Ltd.
37.23ProTom International Holding Corp.
37.24Leo Cancer Care, Inc.
37.25ZAP Surgical Systems, Inc.
37.26iCAD, Inc.
Chapter 38.Partnerships & M&A
Chapter 39.Key Vendor Analysis
39.1Siemens Healthineers AG (Varian Medical Systems, Inc.)
39.2Elekta AB
39.3Accuray Incorporated
39.4Ion Beam Applications S.A. (IBA)
39.5Hitachi, Ltd.
39.6Sumitomo Heavy Industries, Ltd.
39.7Mevion Medical Systems, Inc.
39.8Brainlab AG
39.9RaySearch Laboratories AB
39.10Mirion Technologies, Inc. (Sun Nuclear)
39.11Eckert & Ziegler SE
39.12Novartis AG
39.13Bayer AG
39.14Perspective Therapeutics, Inc.
39.15Theragenics Corporation
39.16CIVCO Medical Solutions
39.17Best Medical International, Inc.
39.18PTW-Freiburg GmbH
39.19Standard Imaging, Inc.
39.20Reflexion Medical, Inc.
39.21Our United Corporation
39.22Shinva Medical Instrument Co., Ltd.
39.23ProTom International Holding Corp.
39.24Leo Cancer Care, Inc.
39.25ZAP Surgical Systems, Inc.
39.26iCAD, Inc.
Chapter 40.Marketing Strategy Analysis, Distributors & Traders
Chapter 41.Outlook of the Market
Chapter 42.Concluding Analyst Note
List of Figures+

Structural index generated from this report's own section headings, not verified against the delivered report's actual figure numbering.

Figure 2.1Top 3 Trends to Watch
Figure 2.4Top Investment Pockets
Figure 2.4.1Market Attractiveness Analysis, By Treatment Modality
Figure 2.4.2Market Attractiveness Analysis, By Technique
Figure 2.4.3Market Attractiveness Analysis, By Product and Service Offering
Figure 2.4.4Market Attractiveness Analysis, By Cancer Type
Figure 2.4.5Market Attractiveness Analysis, By Treatment Intent
Figure 2.4.6Market Attractiveness Analysis, By Fractionation Regimen
Figure 2.4.7Market Attractiveness Analysis, By End User
Figure 2.4.8Market Attractiveness Analysis, By Patient Age Group
Figure 2.4.9Market Attractiveness Analysis, By Procurement Model
Figure 2.5Key Market Participants — Intensity Mapping
Figure 4.2.2.2Data Triangulation
Figure 4.3Flow Of Methodology
Figure 4.4Top-Down / Bottom-Up Approach
Figure 6.1.2Product Differentiation and Positioning Logic
Figure 16.3Global Radiation Oncology Market Share, By Treatment Modality (%)
Figure 17.3Global Radiation Oncology Market Share, By Technique (%)
Figure 18.3Global Radiation Oncology Market Share, By Product and Service Offering (%)
Figure 18.3.4Patient Positioning and Immobilization
Figure 19.3Global Radiation Oncology Market Share, By Cancer Type (%)
Figure 20.3Global Radiation Oncology Market Share, By Treatment Intent (%)
Figure 21.3Global Radiation Oncology Market Share, By Fractionation Regimen (%)
Figure 22.3Global Radiation Oncology Market Share, By End User (%)
Figure 23.3Global Radiation Oncology Market Share, By Patient Age Group (%)
Figure 24.3Global Radiation Oncology Market Share, By Procurement Model (%)
Figure 26.2Share, By Geography, 2020–2034 (%)
Figure 26.3Share, By Geography Analysis, 2025, Market Share and CAGR
List of Tables+

Structural index generated from this report's own section headings, not verified against the delivered report's actual table numbering.

Table 1.3Radiation Oncology Comparison By Segments
Table 4.1.2Market Size Estimation
Table 15.1Global Radiation Oncology Market Size — Total
Table 15.2Market Size, by Segment (By Treatment Modality, By Technique, By Product and Service Offering, By Cancer Type, By Treatment Intent, By Fractionation Regimen, By End User, By Patient Age Group, By Procurement Model)
Table 16.2Global Radiation Oncology Market Size, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 16.3.1.1Market Size, By External Beam Radiation Therapy, 2020–2034, Revenue (USD Billion)
Table 16.3.1.2External Beam Radiation Therapy Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 16.3.1.3External Beam Radiation Therapy Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 16.3.1.4External Beam Radiation Therapy Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 16.3.1.5External Beam Radiation Therapy Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 16.3.1.6External Beam Radiation Therapy Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 16.3.1.7External Beam Radiation Therapy Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 16.3.1.8External Beam Radiation Therapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 16.3.1.9External Beam Radiation Therapy Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 17.2Global Radiation Oncology Market Size, By Technique, 2020–2034, Revenue (USD Billion)
Table 17.3.1.1Market Size, By 3D Conformal Radiotherapy, 2020–2034, Revenue (USD Billion)
Table 17.3.1.23D Conformal Radiotherapy Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 17.3.1.33D Conformal Radiotherapy Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 17.3.1.43D Conformal Radiotherapy Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 17.3.1.53D Conformal Radiotherapy Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 17.3.1.63D Conformal Radiotherapy Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 17.3.1.73D Conformal Radiotherapy Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 17.3.1.83D Conformal Radiotherapy Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 17.3.1.93D Conformal Radiotherapy Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 18.2Global Radiation Oncology Market Size, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 18.3.1.1Market Size, By Treatment Delivery Systems, 2020–2034, Revenue (USD Billion)
Table 18.3.1.2Treatment Delivery Systems Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 18.3.1.3Treatment Delivery Systems Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 18.3.1.4Treatment Delivery Systems Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 18.3.1.5Treatment Delivery Systems Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 18.3.1.6Treatment Delivery Systems Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 18.3.1.7Treatment Delivery Systems Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 18.3.1.8Treatment Delivery Systems Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 18.3.1.9Treatment Delivery Systems Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 19.2Global Radiation Oncology Market Size, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 19.3.1.1Market Size, By Prostate Cancer, 2020–2034, Revenue (USD Billion)
Table 19.3.1.2Prostate Cancer Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 19.3.1.3Prostate Cancer Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 19.3.1.4Prostate Cancer Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 19.3.1.5Prostate Cancer Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 19.3.1.6Prostate Cancer Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 19.3.1.7Prostate Cancer Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 19.3.1.8Prostate Cancer Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 19.3.1.9Prostate Cancer Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 20.2Global Radiation Oncology Market Size, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 20.3.1.1Market Size, By Curative, 2020–2034, Revenue (USD Billion)
Table 20.3.1.2Curative Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 20.3.1.3Curative Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 20.3.1.4Curative Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 20.3.1.5Curative Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 20.3.1.6Curative Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 20.3.1.7Curative Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 20.3.1.8Curative Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 20.3.1.9Curative Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 21.2Global Radiation Oncology Market Size, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 21.3.1.1Market Size, By Conventional Fractionation, 2020–2034, Revenue (USD Billion)
Table 21.3.1.2Conventional Fractionation Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 21.3.1.3Conventional Fractionation Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 21.3.1.4Conventional Fractionation Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 21.3.1.5Conventional Fractionation Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 21.3.1.6Conventional Fractionation Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 21.3.1.7Conventional Fractionation Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 21.3.1.8Conventional Fractionation Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 21.3.1.9Conventional Fractionation Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 22.2Global Radiation Oncology Market Size, By End User, 2020–2034, Revenue (USD Billion)
Table 22.3.1.1Market Size, By Hospitals, 2020–2034, Revenue (USD Billion)
Table 22.3.1.2Hospitals Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 22.3.1.3Hospitals Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 22.3.1.4Hospitals Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 22.3.1.5Hospitals Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 22.3.1.6Hospitals Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 22.3.1.7Hospitals Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 22.3.1.8Hospitals Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 22.3.1.9Hospitals Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 23.2Global Radiation Oncology Market Size, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 23.3.1.1Market Size, By Pediatric, 2020–2034, Revenue (USD Billion)
Table 23.3.1.2Pediatric Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 23.3.1.3Pediatric Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 23.3.1.4Pediatric Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 23.3.1.5Pediatric Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 23.3.1.6Pediatric Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 23.3.1.7Pediatric Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 23.3.1.8Pediatric Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 23.3.1.9Pediatric Size and Projections, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 24.2Global Radiation Oncology Market Size, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 24.3.1.1Market Size, By Outright Purchase, 2020–2034, Revenue (USD Billion)
Table 24.3.1.2Outright Purchase Size and Projections, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 24.3.1.3Outright Purchase Size and Projections, By Technique, 2020–2034, Revenue (USD Billion)
Table 24.3.1.4Outright Purchase Size and Projections, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 24.3.1.5Outright Purchase Size and Projections, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 24.3.1.6Outright Purchase Size and Projections, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 24.3.1.7Outright Purchase Size and Projections, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 24.3.1.8Outright Purchase Size and Projections, By End User, 2020–2034, Revenue (USD Billion)
Table 24.3.1.9Outright Purchase Size and Projections, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 26.1Revenue, By Geography, 2020–2034, Revenue (USD Billion)
Table 26.4Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 27.1Overview, 2020–2034
Table 27.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 27.2.1By Treatment Modality, 2020–2034
Table 27.2.2By Technique, 2020–2034
Table 27.2.3By Product and Service Offering, 2020–2034
Table 27.2.4By Cancer Type, 2020–2034
Table 27.2.5By Treatment Intent, 2020–2034
Table 27.2.6By Fractionation Regimen, 2020–2034
Table 27.2.7By End User, 2020–2034
Table 27.2.8By Patient Age Group, 2020–2034
Table 27.2.9By Procurement Model, 2020–2034
Table 27.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 27.3.1.4US — Market Overview, 2020–2034, Revenue (USD Billion)
Table 27.3.1.5US — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 27.3.1.6US Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 27.3.1.7US Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
Table 27.3.1.8US Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 27.3.1.9US Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 27.3.1.10US Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 27.3.1.11US Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 27.3.1.12US Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 27.3.1.13US Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 27.3.1.14US Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 28.1Overview, 2020–2034
Table 28.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.2.1By Treatment Modality, 2020–2034
Table 28.2.2By Technique, 2020–2034
Table 28.2.3By Product and Service Offering, 2020–2034
Table 28.2.4By Cancer Type, 2020–2034
Table 28.2.5By Treatment Intent, 2020–2034
Table 28.2.6By Fractionation Regimen, 2020–2034
Table 28.2.7By End User, 2020–2034
Table 28.2.8By Patient Age Group, 2020–2034
Table 28.2.9By Procurement Model, 2020–2034
Table 28.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 28.3.1.4Germany — Market Overview, 2020–2034, Revenue (USD Billion)
Table 28.3.1.5Germany — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 28.3.1.6Germany Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 28.3.1.7Germany Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
Table 28.3.1.8Germany Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 28.3.1.9Germany Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 28.3.1.10Germany Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 28.3.1.11Germany Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 28.3.1.12Germany Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 28.3.1.13Germany Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 28.3.1.14Germany Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 29.1Overview, 2020–2034
Table 29.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.2.1By Treatment Modality, 2020–2034
Table 29.2.2By Technique, 2020–2034
Table 29.2.3By Product and Service Offering, 2020–2034
Table 29.2.4By Cancer Type, 2020–2034
Table 29.2.5By Treatment Intent, 2020–2034
Table 29.2.6By Fractionation Regimen, 2020–2034
Table 29.2.7By End User, 2020–2034
Table 29.2.8By Patient Age Group, 2020–2034
Table 29.2.9By Procurement Model, 2020–2034
Table 29.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 29.3.1.4India — Market Overview, 2020–2034, Revenue (USD Billion)
Table 29.3.1.5India — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 29.3.1.6India Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 29.3.1.7India Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
Table 29.3.1.8India Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 29.3.1.9India Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 29.3.1.10India Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 29.3.1.11India Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 29.3.1.12India Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 29.3.1.13India Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 29.3.1.14India Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 30.1Overview, 2020–2034
Table 30.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.2.1By Treatment Modality, 2020–2034
Table 30.2.2By Technique, 2020–2034
Table 30.2.3By Product and Service Offering, 2020–2034
Table 30.2.4By Cancer Type, 2020–2034
Table 30.2.5By Treatment Intent, 2020–2034
Table 30.2.6By Fractionation Regimen, 2020–2034
Table 30.2.7By End User, 2020–2034
Table 30.2.8By Patient Age Group, 2020–2034
Table 30.2.9By Procurement Model, 2020–2034
Table 30.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 30.3.1.4Brazil — Market Overview, 2020–2034, Revenue (USD Billion)
Table 30.3.1.5Brazil — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 30.3.1.6Brazil Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 30.3.1.7Brazil Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
Table 30.3.1.8Brazil Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 30.3.1.9Brazil Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 30.3.1.10Brazil Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 30.3.1.11Brazil Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 30.3.1.12Brazil Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 30.3.1.13Brazil Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 30.3.1.14Brazil Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
Table 31.1Overview, 2020–2034
Table 31.2Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.2.1By Treatment Modality, 2020–2034
Table 31.2.2By Technique, 2020–2034
Table 31.2.3By Product and Service Offering, 2020–2034
Table 31.2.4By Cancer Type, 2020–2034
Table 31.2.5By Treatment Intent, 2020–2034
Table 31.2.6By Fractionation Regimen, 2020–2034
Table 31.2.7By End User, 2020–2034
Table 31.2.8By Patient Age Group, 2020–2034
Table 31.2.9By Procurement Model, 2020–2034
Table 31.3Size and Projections, By Countries, 2020–2034, Revenue (USD Billion)
Table 31.3.1.4GCC — Market Overview, 2020–2034, Revenue (USD Billion)
Table 31.3.1.5GCC — Market Size and Projections, 2020–2034, Revenue (USD Billion)
Table 31.3.1.6GCC Market Overview, By Treatment Modality, 2020–2034, Revenue (USD Billion)
Table 31.3.1.7GCC Market Overview, By Technique, 2020–2034, Revenue (USD Billion)
Table 31.3.1.8GCC Market Overview, By Product and Service Offering, 2020–2034, Revenue (USD Billion)
Table 31.3.1.9GCC Market Overview, By Cancer Type, 2020–2034, Revenue (USD Billion)
Table 31.3.1.10GCC Market Overview, By Treatment Intent, 2020–2034, Revenue (USD Billion)
Table 31.3.1.11GCC Market Overview, By Fractionation Regimen, 2020–2034, Revenue (USD Billion)
Table 31.3.1.12GCC Market Overview, By End User, 2020–2034, Revenue (USD Billion)
Table 31.3.1.13GCC Market Overview, By Patient Age Group, 2020–2034, Revenue (USD Billion)
Table 31.3.1.14GCC Market Overview, By Procurement Model, 2020–2034, Revenue (USD Billion)
Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Radiation Oncology Market projected to reach?

USD 18.7 USD Billion by 2034, CAGR 7.48%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 41% of global revenue through 2034.

05Which segment leads the market?

External Beam Radiation Therapy is the largest line by treatment modality, at 72% of revenue in 2025.

06Who are the key companies profiled?

Siemens Healthineers AG (Varian Medical Systems, Inc.), Elekta AB, Accuray Incorporated, Ion Beam Applications S.A. (IBA), Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Mevion Medical Systems, Inc., Brainlab AG, RaySearch Laboratories AB, Mirion Technologies, Inc. (Sun Nuclear), Eckert & Ziegler SE, Novartis AG, Bayer AG, Perspective Therapeutics, Inc., Theragenics Corporation, CIVCO Medical Solutions, Best Medical International, Inc., PTW-Freiburg GmbH, Standard Imaging, Inc., Reflexion Medical, Inc., Our United Corporation, Shinva Medical Instrument Co., Ltd., ProTom International Holding Corp., Leo Cancer Care, Inc., ZAP Surgical Systems, Inc., iCAD, Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.